Article

Blue Heron Biotechnology has a new CEO

John Fess has been appointed chief executive officer of Blue Heron Biotechnology (Bothell, WA, www.blueheronbio.com).

John Fess has been appointed chief executive officer of Blue Heron Biotechnology (Bothell, WA, www.blueheronbio.com). Fess brings 25 years of experience to Blue Heron and succeeds John Mulligan, PhD, Blue Heron’s founder, who will become the company’s board chairman and chief scientific officer. Previously, as chief operating officer of Blue Heron Bio, Fess oversaw sales, marketing, manufacturing, and information systems, and directed ongoing redesign and deployment of critical business systems. 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
© 2025 MJH Life Sciences

All rights reserved.